calaspargase pegol-mknl
| Brand name | Asparlas |
|---|---|
| Active ingredient | calaspargase pegol-mknl |
| Strength | 3,750UNITS/5ML (750UNITS/ML) |
| Dosage form | Injection |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | December 2018 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.